MedTrace Logo

Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer

NCT00066872 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2013-09-17

No results posted yet for this study

Summary

RATIONALE: Biological therapies such as imiquimod use different ways to stimulate the immune system and stop cancer cells from growing. It is not yet known if topical imiquimod is more effective than surgery in treating basal cell skin cancer.

PURPOSE: This randomized phase III trial is studying how well topical imiquimod works compared to surgery in treating patients with basal cell skin cancer.

Conditions

  • Non-melanomatous Skin Cancer

Interventions

DRUG

imiquimod

PROCEDURE

conventional surgery

Sponsors & Collaborators

  • Queen's Medical Center

    lead OTHER

Principal Investigators

  • Mara Ozolins, MS · Queen's Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-10-31
Completion
2010-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00066872 on ClinicalTrials.gov